Back to medical news
Original source summary
(MedPage Today) -- The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday. The first-in-class drug is a humanized monoclonal...
Verbatim from MedPage Today's own feed — "First At-Home Thyroid Eye Disease Shot Approved"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news